Från 2 betyg inom de senaste 6 månaderna. Detta är inte en investeringsrekommendation.
Köp
50%
Behåll
50%
Sälj
0%
Om
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.